DK397575A - Fremgangsmade til fremstilling af 1,3,4-trisubstituerede 4-arylpiperidiner - Google Patents

Fremgangsmade til fremstilling af 1,3,4-trisubstituerede 4-arylpiperidiner

Info

Publication number
DK397575A
DK397575A DK397575A DK397575A DK397575A DK 397575 A DK397575 A DK 397575A DK 397575 A DK397575 A DK 397575A DK 397575 A DK397575 A DK 397575A DK 397575 A DK397575 A DK 397575A
Authority
DK
Denmark
Prior art keywords
arylpiperidines
trisubstituted
procedure
preparation
Prior art date
Application number
DK397575A
Other languages
English (en)
Other versions
DK153397C (da
DK153397B (da
Inventor
D M Zimmerman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK397575A publication Critical patent/DK397575A/da
Publication of DK153397B publication Critical patent/DK153397B/da
Application granted granted Critical
Publication of DK153397C publication Critical patent/DK153397C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
DK397575A 1974-09-06 1975-09-04 Analogifremgangsmaade til fremstilling af 1,3,4-trisubstituerede 4-arylpiperidiner eller farmaceutisk acceptable syreadditionssalte deraf DK153397C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50358174A 1974-09-06 1974-09-06
US50358174 1974-09-06

Publications (3)

Publication Number Publication Date
DK397575A true DK397575A (da) 1976-03-07
DK153397B DK153397B (da) 1988-07-11
DK153397C DK153397C (da) 1988-12-05

Family

ID=24002675

Family Applications (1)

Application Number Title Priority Date Filing Date
DK397575A DK153397C (da) 1974-09-06 1975-09-04 Analogifremgangsmaade til fremstilling af 1,3,4-trisubstituerede 4-arylpiperidiner eller farmaceutisk acceptable syreadditionssalte deraf

Country Status (27)

Country Link
US (1) US4081450A (da)
JP (3) JPS5929588B2 (da)
AR (1) AR206937A1 (da)
AT (1) AT350567B (da)
BE (1) BE833044A (da)
BG (2) BG24802A3 (da)
CA (1) CA1069901A (da)
CH (1) CH625787A5 (da)
CS (1) CS188237B2 (da)
DD (1) DD121636A5 (da)
DE (1) DE2539452A1 (da)
DK (1) DK153397C (da)
ES (1) ES440771A1 (da)
FR (2) FR2283679A1 (da)
GB (1) GB1525584A (da)
HU (1) HU173057B (da)
IE (1) IE41610B1 (da)
IL (1) IL48003A (da)
NL (1) NL7510535A (da)
NZ (1) NZ178501A (da)
PH (2) PH12618A (da)
PL (3) PL117501B1 (da)
RO (1) RO68142A (da)
SE (1) SE425489B (da)
SU (2) SU629875A3 (da)
YU (2) YU221675A (da)
ZA (1) ZA755614B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284635A (en) * 1978-11-29 1981-08-18 Eli Lilly And Company Analgesic 1,2,4,5-tetra-alkyl-4-arylpiperidines
FR2451368A1 (fr) * 1979-03-12 1980-10-10 Lilly Co Eli Phenylmorphanes, intermediaires et procedes de synthese, et leur utilisation therapeutique
ZA813127B (en) 1980-05-13 1982-05-26 May & Baker Ltd A new phenylpropargylamine derivative
CH646696A5 (de) 1980-11-28 1984-12-14 Sandoz Ag Dibenzazepine, ihre herstellung und verwendung.
FR2518093A2 (fr) * 1980-12-15 1983-06-17 Roussel Uclaf Nouveaux derives de l'hydroxyphenyl tetrahydropyridine, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant
US4931558A (en) * 1983-09-21 1990-06-05 Eli Lilly And Company Processes for preparing intermediates of picenadol
US4581456A (en) * 1983-09-21 1986-04-08 Eli Lilly And Company Processes for preparing picenadol precursors and novel intermediates thereof
US4678638A (en) * 1985-07-24 1987-07-07 Petrolite Corporation Highly branched amino hexahydropyridines
US5319087A (en) * 1987-04-16 1994-06-07 Eli Lilly And Company Piperidine opioid antagonists
ATE110057T1 (de) * 1987-04-16 1994-09-15 Lilly Co Eli Piperidine als opioid-antagoniste.
EP0299549A3 (en) * 1987-07-09 1989-02-08 Duphar International Research B.V Tertiary 2,5-dialkyl-3-phenyl-piperidine derivatives having opiate-antagonistic activity
US5250542A (en) * 1991-03-29 1993-10-05 Eli Lilly And Company Peripherally selective piperidine carboxylate opioid antagonists
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
US5270328A (en) * 1991-03-29 1993-12-14 Eli Lilly And Company Peripherally selective piperidine opioid antagonists
ZA9610741B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
GB9725114D0 (en) * 1997-11-28 1998-01-28 Pfizer Ltd Treatment of pruritus
GB9810671D0 (en) * 1998-05-18 1998-07-15 Pfizer Ltd Anti-pruritic agents
GB9912413D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912416D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912410D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912411D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912415D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912417D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
US7045527B2 (en) * 2002-09-24 2006-05-16 Amgen Inc. Piperidine derivatives
JP6879621B2 (ja) * 2013-07-15 2021-06-02 コーラル サンスクリーン ピーティーワイ リミテッド Ｕｖ吸収化合物、同化合物を含む組成物及びそれらの使用
US10519111B2 (en) 2013-07-15 2019-12-31 Coral Sunscreen Pty Ltd UV absorbing compounds, compositions comprising same and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2892842A (en) * 1959-06-30 Their preparation
DD87036A (da) *
US2075359A (en) * 1930-10-16 1937-03-30 Du Pont Insecticide
US1915334A (en) * 1930-10-16 1933-06-27 Du Pont Fluosilicate of organic heterocyclic bases and process of making it
US3080372A (en) * 1960-03-25 1963-03-05 Res Lab Dr C Janssen 1-aroylalkyl-4-arylpiperidine derivatives
US3936468A (en) * 1969-10-27 1976-02-03 Sumitomo Chemical Company, Ltd. Phenylbutanol derivatives

Also Published As

Publication number Publication date
BG24802A3 (en) 1978-05-12
PL108465B1 (en) 1980-04-30
DD121636A5 (da) 1976-08-12
AT350567B (de) 1979-06-11
CS188237B2 (en) 1979-02-28
US4081450A (en) 1978-03-28
DK153397C (da) 1988-12-05
JPS6026782B2 (ja) 1985-06-25
ZA755614B (en) 1977-04-27
JPS5916875A (ja) 1984-01-28
SE425489B (sv) 1982-10-04
YU221675A (en) 1982-02-28
GB1525584A (en) 1978-09-20
PL100438B1 (pl) 1978-10-31
HU173057B (hu) 1979-02-28
CH625787A5 (da) 1981-10-15
PH12618A (en) 1979-07-05
IL48003A (en) 1981-01-30
ES440771A1 (es) 1977-04-01
IE41610B1 (en) 1980-02-13
JPS6012350B2 (ja) 1985-04-01
JPS5148670A (da) 1976-04-26
FR2283679A1 (fr) 1976-04-02
DK153397B (da) 1988-07-11
AR206937A1 (es) 1976-08-31
FR2283679B1 (da) 1979-09-14
FR2299337A1 (fr) 1976-08-27
RO68142A (ro) 1981-08-30
DE2539452A1 (de) 1976-03-18
FR2299337B1 (da) 1979-01-19
SU629875A3 (ru) 1978-10-25
NL7510535A (nl) 1976-03-09
AU8431375A (en) 1977-03-03
SU621316A3 (ru) 1978-08-25
SE7509640L (sv) 1976-03-08
IE41610L (en) 1976-03-06
JPS5929588B2 (ja) 1984-07-21
YU233681A (en) 1982-02-28
PH14016A (en) 1980-12-08
BG24950A3 (en) 1978-06-15
IL48003A0 (en) 1975-11-25
ATA685275A (de) 1978-11-15
NZ178501A (en) 1978-09-20
JPS6051174A (ja) 1985-03-22
BE833044A (fr) 1976-03-03
PL117501B1 (en) 1981-08-31
CA1069901A (en) 1980-01-15

Similar Documents

Publication Publication Date Title
DK397575A (da) Fremgangsmade til fremstilling af 1,3,4-trisubstituerede 4-arylpiperidiner
DK142237C (da) Kontinuerlig fremgangsmaade til fremstilling af alkoxysilaner
DK138501C (da) Analogifremgangsmaade til fremstilling af 3alfa-hydroxy-d-homo-5alfa-pregnan-11,20-dioner
DK144298C (da) Fremgangsmaade til fremstilling af alkyl-tert-butylethere
DK490775A (da) Fremgangsmade til fremstilling af eventuelt substituerede 1,2,3,5-tetrahydroimidazo(2,1-b)-quinazolin-2-oner
DK179675A (da) Fremgangsmade til fremstilling af 6-amino-5-r3-2,4-diaminopyrimidin-3-oxider
DK164376A (da) Fremgangsmade til fremstilling af 3,4-dihydrospiro-2h-1,3-benzoxaziner
DK554076A (da) Fremgangsmade til fremstilling af 3,4i-dideoxykanamycin ]
DK141849C (da) Fremgangsmaade til fremstilling af slagseje vinylaromat-podecopolymere
DK547475A (da) Fremgangsmade til fremstilling af 8,8-disubstituerede 6-methylergoliner
DK136729C (da) Analogifremgangsmaade til fremstilling af 1alfa,17beta-dihydroxy-17beta-alkynyl-4-oestren-3-oner
DK206375A (da) Fremgangsmade til fremstilling af thiaprostaglandiner
DK390975A (da) Fremgangsmade til fremstilling af omega-nor-cycloalkyl-13,14-dehydroprostaglandiner
DK153479C (da) Analogifremgangsmaade til fremstilling af 1,4-benzodiazepin-2-on-derivater
DK496275A (da) Fremgangsmade til fremstilling af 1,2,3,4-tetrahydroisoquinoliner
DK137539C (da) Fremgangsmaade til fremstilling af 11beta-fluor-4-androsten-3-oner
DK348575A (da) Fremgangsmade til fremstilling af 9,11,15-trihydroxy-13,14-dehydro-prostaglandiner
DK505275A (da) Fremgangsmade til fremstilling af 7,7-diphenylhexahydro-1,4-oxazepiner
DK149803C (da) Fremgangsmaade til fremstilling af 1,2-dichlorethan
DK544476A (da) Fremgangsmade til fremstilling af difluormethyl-1,2,2-trifluorethylether
DK352975A (da) Fremgangsmade til fremstilling af 3beta-(4-oxoalfa-l-rhamnosyl)-14beta-hydroxy-bufa-4,20,22-trienolid
DK474575A (da) Fremgangsmade til fremstilling af 10,11-dihydro-3-carboxycyproheptadin eller n-oxidet deraf
DK132661C (da) Fremgangsmade til fremstilling af 17-acylestere af 17alfa,21-dihydroxysteroider af pregnanrekken
DK233375A (da) Fremgangsmade til fremstilling af substituerede phenylmercapto-benzimidazoler
DK137721C (da) Fremgangsmaade til fremstilling af alfa-oxothiodimethylamider

Legal Events

Date Code Title Description
PBP Patent lapsed